I know this may be like asking, how long is a rope. But I feel that this answer is far more muddled than IB, consulting and other career paths.
Could any of you share insights, or link to a post that does? -- particularly interested in BB's.
| +55 | From long time senior ER analyst: pay attention to II when selecting your junior seat | 11 | 6d | |
| +18 | Josh Schimmers Comp Justifiable? | 43 | 1w | |
| +17 | IB vs ER comp | 15 | 1d | |
| +13 | Analysis of Ulta Beauty | 1 | 22h | |
| +11 | Seeking Advice regarding LO AM Equity Research career progession | 3 | 1w | |
| +10 | Earnings call transcript analysis | 3 | 1w | |
| +10 | Biotech ER | 11 | 1w | |
| +9 | Best way to break into Biotech ER? | 1 | 7h | |
| +6 | Is leerink still a good option | 5 | 4d | |
| +6 | Equity Research Winter Internship / Off Cycle / 6 Month Internship | 1 | 2d |
Career Resources
Get instant access to lessons taught by experienced private equity pros and bulge bracket investment bankers including financial statement modeling, DCF, M&A, LBO, Comps and Excel Modeling.
Worked in an MM's Houston office for ER as a summer internship. The place was still ramping up its energy practice at the time and I was able to click around and find the salary of 2 MDs in the office.
First was a newly promoted MD, basically an outstanding director they poached and promoted from another mm, he has 10-12 years of experience since at the time, base $225k and targeted bonus $225k for all in target $450k. He was considered "fast tracked" and typically it takes a bit longer than that to be an MD.
Second was an all-star MD the bank poached from a top BB to lead one of the verticals. His sign-on was $300k, with buyout of all unvested stocks he has in the BB. The base also $300k, targeted bonus $900k with target all-in of $1.2mm
Depends on the sector. More revenues (trading, banking) typically = higher pay; for example, top biotech analysts make $3 mil + per year.
Here's a WSJ article (link) on biotech senior analyst salaries from 2019..says that "leading analysts in other industries generally receive just over $1 million annually."
bump, this is an interesting topic
Anyone know if there is a premium pay bump if at a BB generally known for good research (i.e., BofA, JPM)? Also does top II ranking matter for this?
interested to know as well on the total comps at the different levels from junior analysts to associates and vps and so on. What is a reasonable range and average? For london numbers as well, if anyone knows
Just a data point but I'm a first year-ish biotech associate with 200k total comp so you can probably have a reasonable MD comp derived from that
Isn't biotech one of the highest paying sectors? Is your comp the same as that of a first year associate at your firm in let's say fintech, or IT services?
Nope. I know other associates in different sectors at my firm with more experience than me but getting comped significantly less
Are you at a BB? Any idea if this comp is similar to that of other hot sectors (tech, medtech/services/pharma, consumer goods)?
Honestly depends on what your bargaining power/background is and if your analyst goes to bat for you. If you're getting poached you have a lot more upside to comp negotiation
What is average all comp for like the 1st 3 years as an analyst, then associate and vp levels? Looking at bb numbers if you have any idea
To clarify, when I say associate I'm using the associate to VP analyst to MD analyst structure with associate as the lowest level as is the norm with most ER places
That said BBs are pretty standardized I believe at base 85/95/105 or something for first 3 years then base 120/140/160 for next 3 followed by around 175 at VP. The biggest delta would be with bonuses- probably 10-20 for first 3, 20-50 next 3, and 50+ at VP depending on industry and any IPOs you're on. Obviously the hotter your sector the bigger your payout at VP and up levels
Idkkkkk I've heard analysts get paid more than associates! Terrible!!
Analyst is the Managing Director. Associates are the junior ppl.
Aren’t there VP and ED level jr analysts?
I thought associate was just analyst to associate (with some rare Sr Associate VPs).
some portfolio manager at Fidelity apparently made 100 mill one year. Heard about this but don't see how true it is.
Have heard some crazy numbers out of Wolfe; think multi year LSD MM guarantees for people they poach
what are some of the numbers youve heard? don't have to name specific names but we are all very curious
it's in my comment?
Yeah so have I. They've been poaching high profile analysts from firms left and right with attractive comps. Myself and colleagues also been approached by them
Makes sense for the top analysts who own their franchise…heard the junior pay isn’t anything special
Similique aliquam quae impedit architecto in fugiat dolorem. Beatae rerum vitae qui ea veritatis. Officia et culpa voluptatem illo.
Ducimus impedit laboriosam mollitia voluptas in aut. Nihil illum dolore temporibus enim. Officia similique perferendis neque rerum.
Officiis totam veritatis autem ipsa voluptas dolorem. Nemo est suscipit temporibus voluptatem. Sint accusantium quo et nisi ut dolores mollitia. Illo et rerum non ut delectus. Facilis ut doloremque atque sit eos nemo.
Natus non et quia quia vero ut voluptas. Autem quod error est quo velit ipsa rerum. Explicabo qui rerum et fugiat facere.
See All Comments - 100% Free
WSO depends on everyone being able to pitch in when they know something. Unlock with your email and get bonus: 6 financial modeling lessons free ($199 value)
or Unlock with your social account...
Harum aut autem rerum unde modi. In accusamus tempore veniam. Odio nihil quis occaecati dolor.
Ut sequi temporibus qui quaerat. Totam dolores architecto reprehenderit adipisci mollitia officiis. Numquam est autem facere velit necessitatibus voluptatem laudantium voluptas. Iusto nam eum eos animi.
Aut explicabo ut aut culpa. Facere voluptates nam id quod qui et. Ipsum laboriosam aliquid consectetur temporibus.
Atque sit architecto et eos non temporibus. A ratione nemo consequatur delectus voluptatem voluptate nam. Velit in fugiat quia.